BioSpace News Archive

Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic’’ or the “Company”), a growth-oriented aerosol manufacturing company focused on natural relief innovations through trusted aerosol delivery, announces today that it has filed it’s S1 and has completed mid-year strategy review in conjunction with the filing.

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the full commercial launch of the FORTOS-C™ Anterior Cervical Plating System.

Athersys, Inc. will release its second quarter 2022 financial results at approximately 4:00 PM Eastern Time on Thursday, August 11, 2022, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.

Forecast to 2030,’ thoroughly examines the Septic Shock industry to provide essential data & information for the targeted readers.

Scientists have developed a cheap, convenient smartphone test for monitoring patients at risk for dangerous blood clots.

New research shows that removing a race modifier from a formula used to diagnose kidney disease could lead to more equitable care for Black patients.

A first-of-its-kind test could make it easier for newborns to get care for spinal muscular atrophy, a common genetic disease that is life-threatening but treatable if caught in time.

Forecast to 2030,’ thoroughly examines the Spinal Muscular Atrophy industry to provide essential data & information for the targeted readers.

Forecast to 2030,’ thoroughly examines the Test Phantoms industry to provide essential data & information for the targeted readers.

Forecast to 2030,’ thoroughly examines the Obsessive Compulsive Disorder industry to provide essential data & information for the targeted readers.